Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Carsten Stoepel"'
Autor:
Carsten Stoepel, Kerstin Bode, Thomas Sarwas, Gerhard Hindricks, Charlotte Eitel, Thomas Gaspar, Bruno Rustum Andrea, Eigk Grebe, Christopher Piorkowski, Holger Thiele, Philipp Sommer
Publikováno v:
Heart Rhythm. 10:46-52
Background Despite modern treatment strategies, cardiogenic shock (CS) is still associated with high mortality. Objective To evaluate the feasibility and safety of temporary percutaneous left ventricular (LV) stimulation as rescue therapy in patients
Publikováno v:
Telemedicine and e-Health. 15:1026-1030
The conventional approach to cardiac implantable device follow-up involves patients attending regularly scheduled in-clinic visits to verify the functionality and safety of the implanted devices. Due to increasing patient volumes, as well as the time
Autor:
Thorsten Schneider, Michael Haude, Hubertus Degen, Uta C. Hoppe, Fotini Dodos, Mathias C. Brandt, Carsten Stoepel, Axel Kroener
Publikováno v:
Catheterization and Cardiovascular Interventions. 74:506-511
Objectives: To assess the feasibility to place a left ventricular lead into the coronary sinus following percutaneous mitral annuloplasty. Background: Percutaneous coronary sinus-based mitral annuloplasty may reduce functional mitral regurgitation in
Publikováno v:
Herz. 34:451-457
Bei Patienten mit systolischer Herzinsuffizienz erhoht eine funktionelle Mitralklappeninsuffizienz (FMI) die Morbiditat. Neben der medikamentosen Therapie und der chirurgischen Mitralklappenrekonstruktion rucken minimalinvasive Behandlungsansatze zun
Publikováno v:
Herz. 34(6)
Morbidity in patients with systolic heart failure is significantly increased by functional mitral valve regurgitation. In addition to pharmaceutical treatment or surgical reconstruction of the impaired valve, minimally invasive procedures have contin
Publikováno v:
EuroIntervention. 5:751-751
Introduction This is the third article in the EuroIntervention Tools & Techniques series and deals with the femoral artery puncture for percutaneous coronary intervention. The following is an overview of its management and highlights the salient tech